Fondazione Serena Onlus - Centro Clinico NeMO Milano
9
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
ALS/MND Natural History Study Data Repository
Role: collaborator
Transition to Adulthood in People With Muscular Dystrophy
Role: collaborator
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Role: collaborator
Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy
Role: collaborator
Trial Readiness and Endpoint Assessment in Congenital and Childhood Myotonic Dystrophy
Role: lead
Poor Neck Proprioception May Cause Balance Deficits in Myotonic Dystrophy 1
Role: collaborator
National Multicenter Interventional Study Aimed at Evaluating the Effect on the Intestinal Microbiota in Chronically Frail Patients Who Share Alterations in Intestinal Function.
Role: collaborator
Upper Limb Assessment in Duchenne Muscular Dystrophy
Role: collaborator
Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS)
Role: collaborator
All 9 trials loaded